Related Experiment Video
Updated: Jan 11, 2026
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
Published on: June 23, 2022
COVID-19 Workplace Testing Study: Phase II Analysis
Dalia Nessim1, Matthew Thiese, Cynthia Ball
1From the School of Medicine, University of Texas at Tyler, Tyler, Texas (D.N., C.B., J.L., K.M.); School of Medicine, University of Utah, Salt Lake City, Utah (M.T.); Biosystems and Agricultural Engineering, Oklahoma State University, Stillwater, Oklahoma (K.M.); College of Public Health, University of South Florida, Tampa, Florida (C.P.); Leonard M. Miller School of Medicine, University of Miami, Miami, Florida (A.J.C.M.); National Institute for Occupational Safety and Health, Cincinnati, Ohio (A.E., P.S.); USDA Forest Service, Washington, DC (A.E.); and Advanced Technologies and Laboratories International Inc, Gaithersburg, Maryland (P.S.).
Background:
US businesses were considerably impacted by the COVID-19 pandemic. Return to work after exposure or illness was challenging.
Objective:
This study aimed to assess employers' experiences and perspectives during the pandemic with SARS-CoV-2 testing in their workforce.
Methods:
An anonymous survey was delivered to employers across nine NORA sectors. Data were analyzed using SAS Version 9.4.
Results:
Thirty percent of the respondents worked in a small-sized company (<100 employees), 28% were 100-500 employees, and 42% were more than 500. Small, medium, and large companies were differentially affected, with larger companies affected the most. Sixty-eight percent reported utilizing testing in their return-to-work strategy. Delay in getting results was the most common reported barrier to testing during the early phase of the pandemic (60%).
Conclusion:
This study will help prepare employers in return-to-work testing decisions in future pandemics.
Related Concept Videos
01:11Clinical Trials: Overview
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...